Skip to main content
TipRanks
Go Ultimate75% OFF

CytomX Therapeutics (CTMX) Q4 2021 Earnings Report

1,006 Followers

CTMX Q4 2021 EPS Results

Actual EPS
-$0.39
Consensus EPS
-$0.35
Beat/Miss
Missed by -$0.04
One Year Ago EPS
-$0.31

CTMX Q4 2021 Revenue Results

Actual Revenue
$19.73M
Expected Revenue
$19.57M
Beat/Miss
Beat by +$153.00K
YoY Revenue Growth
+20.48%

Earnings Announcement Details

Quarter
Q4 2021
Date
03/01/2022
Time
After Close
Conference Call
Tuesday, March 1, 2022
CTMX Upcoming Earnings

CytomX Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q4 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

CTMX Earnings History

CTMX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)-0.08--0.17――
Nov 05, 20262026 (Q3)-0.07-0.09-0.090.00% (+0.00)
Aug 06, 20262026 (Q2)-0.08-0.090―
May 07, 20262026 (Q1)-0.12-0.100.27-137.04% (-0.37)
Mar 16, 20262025 (Q4)-0.09-0.170.22-178.64% (-0.39)
Nov 06, 20252025 (Q3)-0.05-0.090.07-228.57% (-0.16)
Aug 07, 20252025 (Q2)-0.060.00-0.08100.00% (+0.08)
May 12, 20252025 (Q1)0.130.270.1758.82% (+0.10)
Mar 06, 20252024 (Q4)-0.200.220.021000.00% (+0.20)
Nov 07, 20242024 (Q3)-0.170.070.0475.00% (+0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed